- Home
- AVDL vs TILE Comparison
AVDL vs TILE Comparison
Compare AVDL & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- TILE
- Stock Information
- Founded
- AVDL 2015
- TILE 1973
- Country
- AVDL Ireland
- TILE United States
- Employees
- AVDL N/A
- TILE N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- TILE Home Furnishings
- Sector
- AVDL Health Care
- TILE Consumer Discretionary
- Exchange
- AVDL Nasdaq
- TILE Nasdaq
- Market Cap
- AVDL 1.5B
- TILE 1.6B
- IPO Year
- AVDL 1996
- TILE N/A
- Fundamental
- Price
- AVDL $14.35
- TILE $26.86
- Analyst Decision
- AVDL Strong Buy
- TILE Buy
- Analyst Count
- AVDL 8
- TILE 1
- Target Price
- AVDL $20.88
- TILE $32.00
- AVG Volume (30 Days)
- AVDL 1.3M
- TILE 543.2K
- Earning Date
- AVDL 11-11-2025
- TILE 10-31-2025
- Dividend Yield
- AVDL N/A
- TILE 0.15%
- EPS Growth
- AVDL N/A
- TILE 43.35
- EPS
- AVDL N/A
- TILE 1.62
- Revenue
- AVDL $221,075,000.00
- TILE $1,352,215,000.00
- Revenue This Year
- AVDL $64.56
- TILE $7.40
- Revenue Next Year
- AVDL $30.60
- TILE $5.17
- P/E Ratio
- AVDL N/A
- TILE $16.82
- Revenue Growth
- AVDL 132.35
- TILE 6.26
- 52 Week Low
- AVDL $6.38
- TILE $17.24
- 52 Week High
- AVDL $16.66
- TILE $30.20
- Technical
- Relative Strength Index (RSI)
- AVDL 43.90
- TILE 40.19
- Support Level
- AVDL $14.85
- TILE $27.95
- Resistance Level
- AVDL $15.58
- TILE $29.00
- Average True Range (ATR)
- AVDL 0.48
- TILE 0.77
- MACD
- AVDL -0.26
- TILE -0.38
- Stochastic Oscillator
- AVDL 12.16
- TILE 6.39
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.